Litcius/Paper detail

New apoptotic anti-triple-negative breast cancer theobromine derivative inhibiting EGFRWT and EGFRT790M: in silico and in vitro evaluation

Ibrahim H. Eissa, Reda G. Yousef, Hazem Elkady, Aisha A. Alsfouk, Dalal Z. Husein, Ibrahim M. Ibrahim, Nehal M. El‐Deeb, Ahmed M. Kenawy, Wagdy M. Eldehna, Eslam B. Elkaeed, Ahmed M. Metwaly

2023Molecular Diversity20 citationsDOI

Topics & Concepts

AcetamideIn silicoChemistryTheobromineStereochemistryQuinazolinoneIn vitroDocking (animal)SelectivityTriple-negative breast cancerAlkaloidCancerBreast cancerBiochemistryPharmacologyBiologyTheophyllineOrganic chemistryMedicineGeneGeneticsNursingCatalysisCancer therapeutics and mechanismsLung Cancer Treatments and MutationsSynthesis and biological activity
New apoptotic anti-triple-negative breast cancer theobromine derivative inhibiting EGFRWT and EGFRT790M: in silico and in vitro evaluation | Litcius